title: Infective endocarditis--analysis of 116 surgically and 26 medically treated patients.
abstract: We have reviewed 116 cases of bacterial endocarditis treated surgically and 26 cases treated medically since 1973. There were 123 patients with native valve endocarditis and 19 patients with prosthetic valve endocarditis. Overall, the left-sided valves were infected most frequently. There were 10 cases with right-sided valves involved. Multiple valves were infected in 6 patients. There were 6 perioperative deaths in the surgical group. The most common cause of death was multi-organ failure associated with uncontrollable sepsis. The overall operative mortality for active endocarditis was 7.7% (4/55), and for healed endocarditis, 3.3% (2/61). For active native valve endocarditis, the mortality was 4.2% (2/48), for healed native valve endocarditis, 3.6% (2/55), for active prosthetic valve endocarditis, 28.6% (2/7), and for healed prosthetic valve endocarditis, 0%. There was no difference in the operative mortality between active native valve endocarditis and healed native valve endocarditis. The mortality of active prosthetic valve endocarditis was significantly higher than that of active native valve endocarditis (p less than 0.01). Of the 26 patients treated medically, 7 died during the initial hospitalization. The major factor related to mortality in the medically treated patients was persistent sepsis (four patients), and congestive heart failure (three patients). The overall mortality of the medical group for active valve endocarditis was 15% (3/20), and for active prosthetic valve endocarditis, 67% (4/6). We conclude that patients with infective endocarditis with significant valve lesions who are unresponsive to medical therapy should be considered for urgent surgery.
authors.affiliation: Department of Cardiology and Cardiothoracic Surgery, Kobe General Hospital, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Yoshida
authors.forename: J
authors.initials: J
authors.lastname: Yoshikawa
authors.forename: T
authors.initials: T
authors.lastname: Akasaka
authors.forename: T
authors.initials: T
authors.lastname: Hozumi
authors.forename: K
authors.initials: K
authors.lastname: Maeda
authors.forename: F
authors.initials: F
authors.lastname: Okumachi
authors.forename: K
authors.initials: K
authors.lastname: Shiratori
authors.forename: K
authors.initials: K
authors.lastname: Koizumi
authors.forename: H
authors.initials: H
authors.lastname: Kato
authors.forename: Y
authors.initials: Y
authors.lastname: Okada
mesh_terms: D001021:Aortic Valve; D006348:Cardiac Surgical Procedures / Q000401:mortality; D002423:Cause of Death; D004697:Endocarditis, Bacterial / Q000401:mortality / Q000601:surgery* / Q000628:therapy; D006350:Heart Valve Prosthesis / Q000401:mortality; D006801:Humans; D008943:Mitral Valve; D009102:Multiple Organ Failure; D011379:Prognosis; D015996:Survival Rate; D014261:Tricuspid Valve